Found: 41
Select item for more details and to access through your institution.
An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients.
- Published in:
- In Vivo, 2023, v. 37, n. 4, p. 1445, doi. 10.21873/invivo.13228
- By:
- Publication type:
- Article
Clinical outcomes of intermittent panitumumab based-therapy for previously treated older patient with metastatic colorectal cancer: a case report and review of literature.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1369952
- By:
- Publication type:
- Article
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS -mutated metastatic colorectal cancer: the REVOLUTION study protocol.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920929589
- By:
- Publication type:
- Article
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS -mutated metastatic colorectal cancer: the REVOLUTION study protocol.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920929589
- By:
- Publication type:
- Article
Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919899850
- By:
- Publication type:
- Article
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
- Published in:
- BMC Cancer, 2016, v. 16, p. 1
- By:
- Publication type:
- Article
Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1833, doi. 10.3390/jcm12051833
- By:
- Publication type:
- Article
An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 7108, doi. 10.3390/jcm11237108
- By:
- Publication type:
- Article
Learning to Care for the Older People: An Urgent Need in the Daily Practice of Oncologists.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 11, p. 3149, doi. 10.3390/jcm11113149
- By:
- Publication type:
- Article
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1052, doi. 10.3390/cancers14041052
- By:
- Publication type:
- Article
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1330, doi. 10.3390/cancers12051330
- By:
- Publication type:
- Article
Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials.
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 578, doi. 10.3390/cancers11040578
- By:
- Publication type:
- Article
Becoming an older caregiver: A study of gender differences in family caregiving at the end of life.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 1978, doi. 10.1007/s10637-011-9721-6
- By:
- Publication type:
- Article
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 11, p. 3272, doi. 10.1002/cam4.888
- By:
- Publication type:
- Article
Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients.
- Published in:
- Frontiers in Oncology, 2021, p. N.PAG, doi. 10.3389/fonc.2021.602596
- By:
- Publication type:
- Article
Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1471, doi. 10.1007/s00520-011-1235-4
- By:
- Publication type:
- Article
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA Trial.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 190, doi. 10.1016/j.clcc.2023.01.004
- By:
- Publication type:
- Article
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 257, doi. 10.1007/s00280-012-2004-x
- By:
- Publication type:
- Article
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 4, p. 783, doi. 10.1007/s10120-022-01292-y
- By:
- Publication type:
- Article
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 5, p. 825, doi. 10.1007/s10120-016-0681-6
- By:
- Publication type:
- Article
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 7, p. e2118475, doi. 10.1001/jamanetworkopen.2021.18475
- By:
- Publication type:
- Article
Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1035, doi. 10.3390/biomedicines10051035
- By:
- Publication type:
- Article
Colon and Muscle Metastases From Lobular Breast Carcinoma: A Very Rare Entity.
- Published in:
- Breast Journal, 2012, v. 18, n. 1, p. 77, doi. 10.1111/j.1524-4741.2011.01190.x
- By:
- Publication type:
- Article
Gemcitabine and Paclitaxel Every 2 Weeks in Patients With Previously Untreated Urothelial Carcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 12, p. 2652, doi. 10.1002/cncr.24313
- By:
- Publication type:
- Article
Phase II Trial of Oxaliplatin and Tegafur/Uracil and Oral Folinic Acid for Advanced or Metastatic Colorectal Cancer in Elderly Patients.
- Published in:
- Oncology, 2005, v. 69, n. 2, p. 122, doi. 10.1159/000087814
- By:
- Publication type:
- Article
A Phase II Study of Irinotecan Alternated with a Weekly Schedule of Oxaliplatin, High-Dose Leucovorin and 48-Hour Infusion 5-Fluorouracil in Patients with Advanced Colorectal Cancer.
- Published in:
- Oncology, 2004, v. 66, n. 5, p. 371, doi. 10.1159/000079485
- By:
- Publication type:
- Article
Subcutaneous Granulocyte-Macrophage Colony-Stimulating Factor in Mucositis Induced by an Adjuvant 5-Fluorouracil plus Leucovorin Regimen.
- Published in:
- Oncology, 2003, v. 64, n. 4, p. 353, doi. 10.1159/000070293
- By:
- Publication type:
- Article
Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study.
- Published in:
- Oncology, 2002, v. 63, n. 3, p. 232, doi. 10.1159/000065470
- By:
- Publication type:
- Article
A Phase II Study of Irinotecan Alternated with a Weekly Schedule of High-Dose Leucovorin and 48-Hour 5-Fluorouracil Infusion in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2002, v. 62, n. 3, p. 209, doi. 10.1159/000059567
- By:
- Publication type:
- Article
Contemporaneous Bilateral Forearm Triceps Metastases from Adenocarcinoma of the Lung.
- Published in:
- Oncology, 2000, v. 59, n. 1, p. 28, doi. 10.1159/000012133
- By:
- Publication type:
- Article
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e928, doi. 10.1634/theoncologist.2019-0736
- By:
- Publication type:
- Article
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 385, doi. 10.1634/theoncologist.2018-0442
- By:
- Publication type:
- Article
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low‐Risk, Locally Advanced Rectal Cancer (RaP Study/STAR‐03).
- Published in:
- Oncologist, 2018, v. 23, n. 8, p. 912, doi. 10.1634/theoncologist.2017-0484
- By:
- Publication type:
- Article
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
- Published in:
- Oncologist, 2017, v. 22, n. 12, p. 1463, doi. 10.1634/theoncologist.2017-0158
- By:
- Publication type:
- Article
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Does Family Caregiver Burden Differ Between Elderly and Younger Caregivers in Supporting Dying Patients With Cancer? An Italian Study.
- Published in:
- American Journal of Hospice & Palliative Medicine, 2020, v. 37, n. 8, p. 576, doi. 10.1177/1049909119890840
- By:
- Publication type:
- Article